久久亚洲国产成人影院-久久亚洲国产的中文-久久亚洲国产高清-久久亚洲国产精品-亚洲图片偷拍自拍-亚洲图色视频

US EUROPE AFRICA ASIA 中文
Business / Industries

Stem cells offer ray of hope for healthy future

By Alfred Romann in Seoul For China Daily (China Daily) Updated: 2014-06-23 07:08

Regenerative medicine sector needs more financial support from private investors

One of the most important and innovative pharmaceutical companies in Asia has its headquarters in a busy neighborhood of Seoul, nestled between insurance companies and banks, and not far from Seoul National University.

Medipost Co Ltd, launched in 2000 to research and develop stem cell and regenerative medicine products, has emerged as a leader in the space, both regionally and globally. It took a dozen years for the company to launch its first product commercially: Cartistem used to treat repair cartilages in the knee.

Between its founding and its first product launch, Medipost issued new shares six times and split its stock once. It generated some further revenue, mostly by storing umbilical cord blood, using the blood to transplant stem cells, and later by out-licensing products.

But that income was tiny compared to the cost of developing its drugs. Improbably, it managed to attract enough investors to keep going and growing.

That investment is now starting to pay off. Cartistem is just one of three stem cell products approved for sale in South Korea, and Medipost might be the only public company in the country with global ambitions.

"There are not many companies that can deal with global development in the pharmerging market," said Jay Lee, a senior director at Medipost, speaking at a conference in South Korea last month.

The "pharmerging" markets are the emerging markets for pharmaceutical products. China is possibly the biggest, but there are quite a few of them in the region including South Korea and much of the Association of Southeast Asian Nations.

Even Japan, despite its large economy, is considered an emerging market in some ways because it is often years before drugs developed elsewhere make their way down to patients there due to conservative regulations.

But much is changing in the region, particularly in South Korea and Japan. Both countries are embracing often-controversial research into regenerative medicine, including stem cells.

"There is an exceptional example of a new approach in Japan. They are looking very much, as in South Korea, to develop the stem cell space," says Dianne Jackson-Matthews, an Australia-based director at ERA Consulting Group.

For the time being, government support is driving the growth of this particular industry. Private or institutional investors are not yet convinced that taking a risk on a company developing a drug using science few people understand is worthwhile.

Stem cells offer ray of hope for healthy future

Stem cells offer ray of hope for healthy future

 Stem Cell Industrial Park under construction in Wenjiang  Medical experts call for effective stem cell treatment regulation

Previous Page 1 2 3 Next Page

Hot Topics

Editor's Picks
...
...
主站蜘蛛池模板: 国产主播福利精品一区二区 | 亚洲欧美一二三区 | 成人毛片免费播放 | 久久综合给合久久狠狠狠97色69 | 欧美一区二区三区精品 | 亚洲日韩中文字幕在线播放 | 欧美视频一区二区 | 成人国产精品免费网站 | 亚洲视频在线观看 | www.久久在线| 欧美性xxxx18| 精品国产a| 中文字幕区 | 三级成人网| 国产女人成人精品视频 | 天堂视频网站 | 在线毛片观看 | 国产一级大片在线观看 | 亚洲性在线观看 | 完整日本特级毛片 | 人摸人操 | 黄网站色视频免费观看w | 美女一级毛片免费观看 | 亚洲免费专区 | 欧美高清一级毛片免费视 | 经典香港a毛片免费观看 | 日韩精品久久久毛片一区二区 | 国产啪精品视频网免费 | 成人男女网18免费0 成人男女网18免费看 | 日韩国产成人资源精品视频 | 另类视频区第一页 | 免费一级毛片私人影院a行 免费一级毛片无毒不卡 | 久草视频福利在线 | 日本视频播放免费线上观看 | 国产精品亚洲片在线观看不卡 | 免费的一级片网站 | 亚洲精品资源网在线观看 | 自拍偷拍视频在线观看 | 久久精品国产99国产精品免费看 | 亚洲色欧美 | 成年免费网站 |